Long-term effects of melatonin on quality of life and sleep in haemodialysis patients (Melody study): A randomized controlled trial

British Journal of Clinical Pharmacology

Volumn 76, Issue 5, 2013, Pages 668-679

  Russcher, Marije ^a   Koch, Birgit C P ^b   Nagtegaal, J Elsbeth ^a   van Ittersum, Frans J ^c   Pasker de Jong, Pieternel C M ^a   Hagen, E Chris ^a   van Dorp, Wim Th ^d   Gabreëls, Bas ^e   Wildbergh, Thierry X ^a   van der Westerlaken, Monique M L ^a   Gaillard, Carlo A J M ^a,c   ter Wee, Piet M ^c  

^a MEANDER MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Kennemer Gasthuis ^*  (Netherlands)

^e RIJNLAND HOSPITAL   (Netherlands)

Author keywords

Actigraphy; Haemodialysis; Melatonin; Quality of life; Sleep wake rhythm

Indexed keywords

MELATONIN; PLACEBO;

ACTIMETRY; ADULT; AGED; AMBULATORY BLOOD PRESSURE; ARTICLE; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ECHOCARDIOGRAPHY; EPWORTH SLEEPINESS SCALE; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SALIVA ANALYSIS; SALIVA LEVEL; SHORT FORM 36; SLEEP; SLEEP PARAMETERS; SLEEP TIME; SUPPLEMENTATION; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ACTIGRAPHY; HAEMODIALYSIS; MELATONIN; QUALITY OF LIFE; SLEEP-WAKE RHYTHM;

ACTIGRAPHY; AGED; ANTIOXIDANTS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELATONIN; MIDDLE AGED; QUALITY OF LIFE; RENAL DIALYSIS; SALIVA; SLEEP; SLEEP DISORDERS, CIRCADIAN RHYTHM; TIME FACTORS;

EID: 84885944074     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12093     Document Type: Article

References (48)

1. Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, Locatelli F, MacLeod A, Vanholder R, Walker R, Wang H. The burden of kidney disease: improving global outcomes. Kidney Int 2004; 66: 1310-1314.
2. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007; 72: 247-259.
3. Parker KP. Sleep disturbances in dialysis patients. Sleep Med Rev 2003; 7: 131-143.
4. Parker KP, Bliwise DL, Bailey JL, Rye DB. Daytime sleepiness in stable hemodialysis patients. Am J Kidney Dis 2003; 41: 394-402.
5. Araujo SM, Bruin VM, Daher EF, Medeiros CA, Almeida GH, Bruin PF. Quality of sleep and daytime sleepiness in chronic hemodialysis: a study of 400 patients. Scand J Urol Nephrol 2011; 45: 359-364.
6. Araujo SM, de Bruin V, Daher ED, Almeida GH, Medeiros CA, de Bruin PF. Risk factors for depressive symptoms in a large population on chronic hemodialysis. Int Urol Nephrol 2012; 44: 1229-1235.
7. Parker KP, Kutner NG, Bliwise DL, Bailey JL, Rye DB. Nocturnal sleep, daytime sleepiness, and quality of life in stable patients on hemodialysis. Health Qual Life Outcomes 2003; 1: 68-77.
8. Chen HY, Cheng IC, Pan YJ, Chiu YL, Hsu SP, Pai MF, Yang JY, Peng YS, Tsai TJ, Wu KD. Cognitive-behavioral therapy for sleep disturbance decreases inflammatory cytokines and oxidative stress in hemodialysis patients. Kidney Int 2011; 80: 415-422.
9. Koch BC, Nagtegaal JE, Hagen EC, van Dorp WT, Boringa JB, Kerkhof GA, Ter Wee PM. Subjective sleep efficiency of hemodialysis patients. Clin Nephrol 2008; 70: 411-416.
10. Golombek DA, Rosenstein RE. Physiology of circadian entrainment. Physiol Rev 2010; 90: 1063-1102.
11. Doi M, Takahashi Y, Komatsu R, Yamazaki F, Yamada H, Haraguchi S, Emoto N, Okuno Y, Tsujimoto G, Kanematsu A, Ogawa O, Todo T, Tsutsui K, Van der Horst GT, Okamura H. Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat Med 2010; 16: 67-74.
12. Gumz ML, Stow LR, Lynch IJ, Greenlee MM, Rudin A, Cain BD, Weaver DR, Wingo CS. The circadian clock protein Period 1 regulates expression of the renal epithelial sodium channel in mice. J Clin Invest 2009; 119: 2423-2434.
13. Stow LR, Gumz ML. The circadian clock in the kidney. J Am Soc Nephrol 2011; 22: 598-604.
14. Marcheva B, Ramsey KM, Buhr ED, Kobayashi Y, Su H, Ko CH, Ivanova G, Omura C, Mo S, Vitaterna MH, Lopez JP, Philipson LH, Bradfield CA, Crosby SD, JeBaily L, Wang X, Takahashi JS, Bass J. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 2010; 466: 627-631.
15. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology 2001; 12: 74-77.
16. Shirayama M, Shirayama Y, Iida H, Kato M, Kajimura N, Watanabe T, Sekimoto M, Shirakawa S, Okawa M, Takahashi K. The psychological aspects of patients with delayed sleep phase syndrome (DSPS). Sleep Med 2003; 4: 427-433.
17. Claustrat B, Brun J, Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev 2005; 9: 11-24.
18. Arendt J. Melatonin and human rhythms. Chronobiol Int 2006; 23: 21-37.
19. Brzezinski A. Melatonin in humans. N Engl J Med 1997; 336: 186-195.
20. Koch BC, van der Putten K, Van Someren EJ, Wielders JP, Ter Wee PM, Nagtegaal JE, Gaillard CA. Impairment of endogenous melatonin rhythm is related to the degree of chronic kidney disease (CREAM study). Nephrol Dial Transplant 2010; 25: 513-519.
21. Koch BC, Nagtegaal JE, Hagen EC, van der Westerlaken MM, Boringa JB, Kerkhof GA, Ter Wee PM. The effects of melatonin on sleep-wake rhythm of daytime haemodialysis patients: a randomized, placebo-controlled, crossover study (EMSCAP study). Br J Clin Pharmacol 2009; 67: 68-75.
22. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Bjorklund-Bodegard K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Wang J, Sandoya E, O'Brien E, Staessen JA, International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO) investigators. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007; 370: 1219-1229.
23. Rahman M, Griffin V, Heyka R, Hoit B. Diurnal variation of blood pressure; reproducibility and association with left ventricular hypertrophy in hemodialysis patients. Blood Press Monit 2005; 10: 25-32.
24. Jonas M, Garfinkel D, Zisapel N, Laudon M, Grossman E. Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. Blood Press 2003; 12: 19-24.
25. Van der Zee KI, Sanderman R. Het Meten Van De Algemene Gezondheidstoestand Met De RAND-36: Een Handleiding [Measurement of General Health with the RAND-36: A Manual]. Groningen: Noordelijk Centrum voor Gezondheidsvraagstukken NCG, 1993.
26. Morgenthaler T, Alessi C, Friedman L, Owens J, Kapur V, Boehlecke B, Brown T, Chesson A Jr, Coleman J, Lee-Chiong T, Pancer J, Swick TJ. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep 2007; 30: 519-529.
27. Koch BC, Nagtegaal JE, Hagen EC, Boringa JB, Kerkhof GA, Ter Wee PM. Is actigraphy a valid alternative to PSG for sleep measures in hemodialysis patients? J Am Soc Nephrol 2007; 18: F-PO865.
28. Oakley N. Validation with Polysomnography of the Sleep Watch: Sleep/Wake Scoring Algorithm Used by the Actiwatch Activity Monitoring System. Cambridge Neurotechnology: Technical report to Mini Mitter Co, Inc., 1997.
29. Carskadon MA, Rechtschaffen A. Monitoring and staging human sleep. In: Principles and Practice of Sleep Medicine, 4 edn. eds Kryger MH, Roth T, Dement WC. Philadelphia, PA: Elsevier-Saunders, 2005; 1359-1377.
30. Nagtegaal JE, Kerkhof GA, Smits MG, Swart AC, van der Meer YG. Delayed sleep phase syndrome: a placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset. J Sleep Res 1998; 7: 135-143.
31. Nagtegaal JE, Laurant MW, Kerkhof GA, Smits MG, van der Meer YG, Coenen AM. Effects of melatonin on the quality of life in patients with delayed sleep phase syndrome. J Psychosom Res 2000; 48: 45-50.
32. Twisk JWR. Applied Longitudinal Data Analysis for Epidemiology. Cambridge: Cambridge University Press, 2003.
33. Ekmekcioglu C. Melatonin receptors in humans: biological role and clinical relevance. Biomed Pharmacother 2006; 60: 97-108.
34. Kripke DF, Langer RD, Kline LE. Hypnotics' association with mortality or cancer: a matched cohort study. BMJ Open 2012; 2: e000850.
35. Witt-Enderby PA, Bennett J, Jarzynka MJ, Firestine S, Melan MA. Melatonin receptors and their regulation: biochemical and structural mechanisms. Life Sci 2003; 72: 2183-2198.
36. Wilson SJ, Nutt DJ, Alford C, Argyropoulos SV, Baldwin DS, Bateson AN, Britton TC, Crowe C, Dijk DJ, Espie CA, Gringras P, Hajak G, Idzikowski C, Krystal AD, Nash JR, Selsick H, Sharpley AL, Wade AG. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol 2010; 24: 1577-1601.
37. Ludemann P, Zwernemann S, Lerchl A. Clearance of melatonin and 6-sulfatoxymelatonin by hemodialysis in patients with end-stage renal disease. J Pineal Res 2001; 31: 222-227.
38. Lemoine P, Nir T, Laudon M, Zisapel N. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. J Sleep Res 2007; 16: 372-380.
39. Waldhauser F, Waldhauser M, Lieberman HR, Deng MH, Lynch HJ, Wurtman RJ. Bioavailability of oral melatonin in humans. Neuroendocrinology 1984; 39: 307-313.
40. Shochat T, Haimov I, Lavie P. Melatonin - the key to the gate of sleep. Ann Med 1998; 30: 109-114.
41. Isobe Y, Torri T, Konishi E, Fujioi J. Effects of melatonin injection on running-wheel activity and body temperature differ by the time of day. Pharmacol Biochem Behav 2002; 73: 805-811.
42. Nakahara K, Kawano T, Shiota K, Murakami N. Effects of microinjection of melatonin into various brain regions of Japanese quail on locomotor activity and body temperature. Neurosci Lett 2003; 345: 117-120.
43. Reiter RJ. The pineal and its hormones in the control of reproduction in mammals. Endocr Rev 1980; 1: 109-131.
44. Malpaux B, Robinson JE, Brown MB, Karsch FJ. Reproductive refractoriness of the ewe to inductive photoperiod is not caused by inappropriate secretion of melatonin. Biol Reprod 1987; 36: 1333-1341.
45. Koch BC, Hagen EC, Nagtegaal JE, Boringa JB, Kerkhof GA, Ter Wee PM. Effects of nocturnal hemodialysis on melatonin rhythm and sleep-wake behavior: an uncontrolled trial. Am J Kidney Dis 2009; 53: 658-664.
46. Escames G, Ozturk G, Bano-Otalora B, Pozo MJ, Madrid JA, Reiter RJ, Serrano E, Concepción M, Acuña-Castroviejo D. Exercise and melatonin in humans: reciprocal benefits. J Pineal Res 2012; 52: 1-11.
47. Lewy A. Clinical implications of the melatonin phase response curve. J Clin Endocrinol Metab 2010; 95: 3158-3160.
48. Burgess HJ, Savic N, Sletten T, Roach G, Gilbert SS, Dawson D. The relationship between the dim light melatonin onset and sleep on a regular schedule in young healthy adults. Behav Sleep Med 2003; 1: 102-114.